T cell engineering for adoptive T cell therapy: safety and receptor avidity

Elvira D’Ippolito(Fondazione IRCCS Istituto Nazionale dei Tumori), Dirk H. Busch(German Center for Infection Research), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Magdalena Nauerth(Technical University of Munich)
Cancer Immunology Immunotherapy
September 21, 2019
Cited by 47


Related Papers